135 related articles for article (PubMed ID: 2170079)
41. Sequential respiratory syncytial virus and cytomegalovirus pneumonia following bone marrow transplantation.
Kapelushnik J; Engelhard D; Mehta J; Or R; Brandstetter Y; Picard E; Cividalli G; Nagler A
J Med Virol; 1995 Jun; 46(2):169-71. PubMed ID: 7636507
[TBL] [Abstract][Full Text] [Related]
42. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Ljungman P
Semin Respir Infect; 1995 Dec; 10(4):209-15. PubMed ID: 8668848
[TBL] [Abstract][Full Text] [Related]
43. Specific hyperimmune globulin for cytomegalovirus pneumonitis.
Blacklock HA; Griffiths P; Stirk P; Prentice HG
Lancet; 1985 Jul; 2(8447):152-3. PubMed ID: 2862339
[No Abstract] [Full Text] [Related]
44. CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies.
Hebart H; Einsele H; Klein R; Fischer I; Bühler S; Dietz K; Jahn G; Berg PA; Kanz L; Müller CA
Br J Haematol; 1996 Oct; 95(1):138-44. PubMed ID: 8857952
[TBL] [Abstract][Full Text] [Related]
45. The lung as a critical organ in marrow transplantation.
Quabeck K
Bone Marrow Transplant; 1994; 14 Suppl 4():S19-28. PubMed ID: 7728120
[TBL] [Abstract][Full Text] [Related]
46. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
Funada H; Harada M; Yoshida T; Hattori K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
[TBL] [Abstract][Full Text] [Related]
48. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
49. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group.
Takenaka K; Gondo H; Tanimoto K; Nagafuji K; Fujisaki T; Mizuno S; Miyamoto T; Okamura T; Hayashi S; Eto T; Osaki K; Yamasaki K; Shibuya T; Harada N; Teshima T; Matsuishi E; Minematsu T; Minamishima Y; Harada M; Niho Y
Bone Marrow Transplant; 1997 Feb; 19(3):241-8. PubMed ID: 9028553
[TBL] [Abstract][Full Text] [Related]
50. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
Boland GJ; Vlieger AM; Ververs C; De Gast GC
Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
[TBL] [Abstract][Full Text] [Related]
51. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.
Thirman MJ; Devine SM; O'Toole K; Cizek G; Jessurun J; Hertz M; Geller RB
Bone Marrow Transplant; 1992 Sep; 10(3):307-11. PubMed ID: 1422484
[TBL] [Abstract][Full Text] [Related]
52. Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation.
Horak DA; Schmidt GM; Zaia JA; Niland JC; Ahn C; Forman SJ
Chest; 1992 Nov; 102(5):1484-90. PubMed ID: 1330449
[TBL] [Abstract][Full Text] [Related]
53. Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia.
Bowden RA; Dobbs S; Kopecky KJ; Crawford S; Meyers JD
J Infect Dis; 1988 Oct; 158(4):773-9. PubMed ID: 2844915
[TBL] [Abstract][Full Text] [Related]
54. Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: findings in the era of serum cytomegalovirus antigen surveillance.
Feinstein MB; Mokhtari M; Ferreiro R; Stover DE; Jakubowski A
Chest; 2001 Oct; 120(4):1094-100. PubMed ID: 11591544
[TBL] [Abstract][Full Text] [Related]
55. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.
Schmidt GM; Horak DA; Niland JC; Duncan SR; Forman SJ; Zaia JA
N Engl J Med; 1991 Apr; 324(15):1005-11. PubMed ID: 1848679
[TBL] [Abstract][Full Text] [Related]
56. Successful management of CMV pneumonia in a mechanically ventilated patient.
Sommer SE; Emanuel D; Groeger JS; Carlon GC
Chest; 1991 Sep; 100(3):856-8. PubMed ID: 1653682
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
[TBL] [Abstract][Full Text] [Related]
58. Cytomegalovirus infection.
Jacobson MA; Mills J
Clin Chest Med; 1988 Sep; 9(3):443-8. PubMed ID: 2842110
[TBL] [Abstract][Full Text] [Related]
59. Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegaloviral pneumonia.
Shepp DH; Newton BA; Meyers JD
J Infect Dis; 1984 Nov; 150(5):776-7. PubMed ID: 6092489
[No Abstract] [Full Text] [Related]
60. Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation.
Mathew P; Bozeman P; Krance RA; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 Feb; 13(2):221-3. PubMed ID: 8205095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
